Jagsonpal Pharmaceuticals Ltd Q1 FY2025-26 net profit climbs to Rs. 10.79 crores

has reported Standalone financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 78.437 crores during the period ended June 30, 2025 as compared to Rs. 61.330 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 10.795 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 6.583 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 1.58 for the period ended June 30, 2025 as compared to Rs. 0.98 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 78.437 crs	₹61.330 crs	27.89%
Net Profit	₹10.795 crs	₹6.583 crs	63.98%
EPS	₹1.58	₹0.98	61.22%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 78.437 crores during the period ended June 30, 2025 as compared to Rs.62.883 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.10.795 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.5.329 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.1.58 for the period ended June 30, 2025 as compared to Rs.0.77 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 78.437 crs	₹62.883 crs	24.73%
Net Profit	₹10.795 crs	₹5.329 crs	102.57%
EPS	₹1.58	₹0.77	105.19%

Source : Equity Bulls

Keywords

JagsonpalPharmaceuticals Q1FY26 Q1FY2026 FY2026 ResultUpdate